Jeil Pharmaceutical Co.,Ltd (KRX:271980)
South Korea · Delayed Price · Currency is KRW 14,960
+400 (2.75%)
At close: Mar 13, 2026
KRX:271980 Market Cap
KRX:271980 has a market cap or net worth of 212.16 billion as of March 12, 2026. Its market cap has increased by 31.17% in one year.
Market Cap
212.16B
Enterprise Value
288.20B
Revenue
621.98B
Ranking
n/a
PE Ratio
10.80
Stock Price
14,960.00
Market Cap Chart
Since March 15, 2022, KRX:271980's market cap has decreased from 390.14B to 212.16B, a decrease of -45.62%. That is a compound annual growth rate of -14.14%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 12, 2026 | 212.16B | -3.89% |
| Dec 30, 2025 | 220.76B | 32.89% |
| Dec 30, 2024 | 166.12B | -33.33% |
| Dec 28, 2023 | 249.17B | -18.65% |
| Dec 29, 2022 | 306.28B | -21.50% |
| Mar 15, 2022 | 390.14B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Ilyang Pharmaceutical Co.,Ltd | 233.92B |
| Chong Kun Dang Holdings | 228.27B |
| Suheung | 227.39B |
| Daewon Pharmaceutical | 219.05B |
| Samjin Pharmaceuticals | 217.58B |
| Samil Pharmaceutical Co.,Ltd | 213.78B |
| HLB Pharmaceutical | 212.88B |
| JW Lifescience | 196.81B |